| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glucocorticoid induced 1 | 0.716 | 0.385 | 5.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
ankyrin repeat and SOCS box containing 2 | 0.769 | 0.308 | 6.8E-15 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
SUFU negative regulator of hedgehog signaling | 0.493 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAD50 double strand break repair protein | 0.556 | 0.808 | 3.4E-27 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAS guanyl releasing protein 4 | 0.780 | 0.231 | 3.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
KLF3 antisense RNA 1 | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||||||
|
atypical chemokine receptor 2 | 0.641 | 0.615 | 1.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2011 | 2019 | |||||||||
|
D-2-hydroxyglutarate dehydrogenase | 0.691 | 0.500 | 5.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
growth factor receptor bound protein 10 | 0.628 | 0.615 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
CD200 receptor 1 | 0.623 | 0.769 | 4.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
anaphase promoting complex subunit 1 | 0.743 | 0.385 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
cytochrome P450 family 8 subfamily B member 1 | 0.711 | 0.269 | 2.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
phosphoribosyl transferase domain containing 1 | 0.805 | 0.385 | 2.4E-13 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
bromodomain PHD finger transcription factor | 0.560 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
zinc finger CCCH-type containing 7B | 0.805 | 0.192 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAD51 paralog B | 0.556 | 0.769 | 2.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
IKAROS family zinc finger 3 | 0.608 | 0.692 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2019 | ||||||||
|
RAB5B, member RAS oncogene family | 0.722 | 0.346 | 2.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
phospholipase C like 2 | 0.743 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 |